 | Up a level |
Muro, Kei and Lordick, Florian and Tsushima, Takahiro and Pentheroudakis, George and Baba, Eishi and Lu, Zhihao and Cho, Byoung Chul and Nor, I.M. and Ng, Matthew and Chen, Li Tzong and Kato, Ken and Li, Jin and Ryu, Min-hee and Wan Zamaniah, Wan Ishak and Yong, Wei Peng and Yeh, Kun Huei and Nakajima, Takako Eguchi and Shitara, Kouhei and Kawakami, Hisato and Narita, Yukiya and Yoshino, Takayuki and Van Cutsem, Eric and Martinelli, Erika and Smyth, Elizabeth C. and Arnold, Dirk and Minami, Hironobu and Tabernero, J. and Douillard, Jean Yves (2019) Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS. Annals of Oncology, 30 (1). pp. 34-43. ISSN 0923-7534, DOI https://doi.org/10.1093/annonc/mdy498.
Muro, Kei and Van Cutsem, Eric and Narita, Yukiya and Pentheroudakis, George and Baba, Eishi and Li, Jin and Ryu, Min-hee and Wan Zamaniah, Wan Ishak and Yong, Wei Peng and Yeh, Kun Huei and Kato, Ken and Lu, Zhihao and Cho, Byoung Chul and Nor, I.M. and Ng, Matthew and Chen, Li Tzong and Nakajima, Takako Eguchi and Shitara, Kouhei and Kawakami, Hisato and Tsushima, Takahiro and Yoshino, Takayuki and Lordick, Florian and Martinelli, Erika and Smyth, Elizabeth C. and Arnold, Dirk and Minami, Hironobu and Tabernero, J. and Douillard, Jean Yves (2019) Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS. Annals of Oncology, 30 (1). pp. 19-33. ISSN 0923-7534, DOI https://doi.org/10.1093/annonc/mdy502.
Park, Keunchil and Vansteenkiste, J. and Lee, K.H. and Pentheroudakis, G. and Zhou, C. and Prabhash, K. and Seto, T. and Voon, P.J. and Tan, D.S.W. and Yang, J.C.H. and Wang, J. and Babu, K. Govind and Nakayama, Y. and Alip, Adlinda and Chua, K.L.M. and Cheng, J.C.-H. and Senan, S. and Ahn, Y.C. and Kim, T.-Y. and Ahn, H.K. and Peters, S. and Yoshino, T. and Douillard, J.-Y. (2020) Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS. Annals of Oncology, 31 (2). pp. 191-201. ISSN 0923-7534, DOI https://doi.org/10.1016/j.annonc.2019.10.026.
Passaro, A. and Wang, J. and Wang, Y. and Lee, S. -H. and Melosky, B. and Shih, J. -Y. and Wang, J. and Azuma, K. and Juan-Vidal, O. and Cobo, M. and Felip, E. and Girard, N. and Cortot, A. B. and Califano, R. and Cappuzzo, F. and Owen, S. and Popat, S. and Tan, J. -l. and Salinas, J. and Tomasini, P. and Gentzler, R. D. and William, W. N. and Reckamp, K. L. and Takahashi, T. and Ganguly, S. and Kowalski, D. M. and Bearz, A. and MacKean, M. and Barala, P. and Bourla, A. B. and Girvin, A. and Greger, J. and Millington, D. and Withelder, M. and Xie, J. and Sun, T. and Shah, S. and Diorio, B. and Knoblauch, R. E. and Bauml, J. M. and Campelo, R. G. and Cho, B. C. and Investigators, MARIPOSA-2 (2024) Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study. Annals of Oncology, 35 (1). ISSN 0923-7534, DOI https://doi.org/10.1016/j.annonc.2023.10.117.
Wu, Y.L. and Zhou, C. and Liam, Chong Kin and Wu, G. and Liu, X. and Zhong, Z. and Lu, S. and Cheng, Y. and Han, B. and Chen, L. and Huang, C. and Qin, S. and Zhu, Y. and Pan, H. and Liang, H. and Li, E. and Jiang, G. and How, S.H. and Fernando, M.C.L. and Zhang, Y. and Xia, F. and Zuo, Y. (2015) First-line erlotinib versus gemcitabine/cisplatin in patients with advancedEGFRmutation-positive non-small-cell lung cancer: analyses from the phase III, randomized, open-label, ENSURE study. Annals of Oncology, 26 (9). pp. 1883-1889. ISSN 0923-7534, DOI https://doi.org/10.1093/annonc/mdv270.
